TCRR - TCR2 Therapeutics appoints Peter Olagunju as CTO
Dr_Microbe/iStock via Getty Images TCR2 Therapeutics (TCRR) has appointed Peter Olagunju as Chief Technical Officer where he will oversee process development, manufacturing, quality control and technical operations for the Company's TRuC-T cell programs and emerging pipeline. Olagunju brings to TCR2 over 20 years of experience in cell and gene therapy, clinical development, program management, manufacturing and technical operations. Most recently, served as Senior Vice President of Technical Operations at FerGene.
For further details see:
TCR2 Therapeutics appoints Peter Olagunju as CTO